BioSpace News Archive

Telix Pharmaceuticals Limited advises that Dr Christian Behrenbruch , Group CEO and Managing Director, will be presenting at the Jefferies London Healthcare Conference 2022.

Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted PRAC’s recommendation to add measures to minimise risk of serious side effects with JAK inhibitors for chronic inflammatory disorders.

Mind Medicine today announced that members of the Company’s management team will participate in the Jefferies London Healthcare Conference.

Fennec Pharmaceuticals Inc. today reported its financial results for the fiscal quarter ended September 30, 2022 and provided a business update.

Click Therapeutics, Inc. today announced that company management will participate in the following investor conferences in November and December.

Apexigen, Inc. today announced new data from an ongoing Phase 2 investigator-sponsored trial evaluating intratumoral sotigalimab (sotiga), Apexigen’s CD40 agonist antibody, in combination with systemic pembrolizumab (anti-PD-1 antibody) in first-line metastatic melanoma.

Rallybio Corporation today announced its participation in the following upcoming investor conferences.

Promontory Therapeutics Inc. today presented data on lead therapeutic candidate PT-112 and its immunological effects on cancer cell mitochondria at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC).

Tremeau Pharmaceuticals will present two abstracts highlighting a potential path forward for rofecoxib, the active ingredient in VIOXX, as a non-opioid treatment option during the American College of Rheumatology’s (ACR) Convergence Meeting in Philadelphia.

VBI Vaccines Inc. today announced that its abstract highlighting data from the ongoing Phase 2a study of VBI-1901, the Company’s cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), was accepted for poster presentation at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology Annual Meeting.